Argentina Neurodegenerative Disease Market (2025-2031) | Industry, Size & Revenue, Outlook, Competitive Landscape, Share, Trends, Companies, Growth, Segmentation, Analysis, Value, Forecast

Name: Argentina Neurodegenerative Disease Market (2025-2031) | Industry & Size
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) And Competitive Landscape

Product Code: ETC6142845	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

Argentina Neurodegenerative Disease Market Outlook
Market Size of Argentina Neurodegenerative Disease Market, 2024
Forecast of Argentina Neurodegenerative Disease Market, 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Revenues & Volume for the Period 2021- 2031
Argentina Neurodegenerative Disease Market Trend Evolution
Argentina Neurodegenerative Disease Market Drivers and Challenges
Argentina Neurodegenerative Disease Price Trends
Argentina Neurodegenerative Disease Porter's Five Forces
Argentina Neurodegenerative Disease Industry Life Cycle
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Indication Type for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Parkinson's Disease for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Alzheimer's Disease for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Huntington Disease for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Other Indication Types for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By N-methyl-D-aspartate Receptor Antagonists for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Immunomodulatory Drugs for the Period 2021- 2031
Historical Data and Forecast of Argentina Neurodegenerative Disease Market Revenues & Volume By Other Drug Types for the Period 2021- 2031
Argentina Neurodegenerative Disease Import Export Trade Statistics
Market Opportunity Assessment By Indication Type
Market Opportunity Assessment By Drug Type
Argentina Neurodegenerative Disease Top Companies Market Share
Argentina Neurodegenerative Disease Competitive Benchmarking By Technical and Operational Parameters
Argentina Neurodegenerative Disease Company Profiles
Argentina Neurodegenerative Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Argentina Neurodegenerative Disease Market Overview

3.1 Argentina Country Macro Economic Indicators

3.2 Argentina Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F

3.3 Argentina Neurodegenerative Disease Market - Industry Life Cycle

3.4 Argentina Neurodegenerative Disease Market - Porter's Five Forces

3.5 Argentina Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F

3.6 Argentina Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4 Argentina Neurodegenerative Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurodegenerative diseases in Argentina

4.2.2 Rising healthcare expenditure and government initiatives to improve neurological care

4.2.3 Technological advancements in diagnostic tools and treatment options

4.3 Market Restraints

4.3.1 Limited access to specialized healthcare services in remote areas of Argentina

4.3.2 High cost of neurodegenerative disease treatments

4.3.3 Lack of awareness and education about neurodegenerative diseases among the general population

5 Argentina Neurodegenerative Disease Market Trends

6 Argentina Neurodegenerative Disease Market, By Types

6.1 Argentina Neurodegenerative Disease Market, By Indication Type

6.1.1 Overview and Analysis

6.1.2 Argentina Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F

6.1.3 Argentina Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.1.4 Argentina Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.1.5 Argentina Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.6 Argentina Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F

6.1.7 Argentina Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F

6.2 Argentina Neurodegenerative Disease Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 Argentina Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F

6.2.3 Argentina Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.4 Argentina Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.5 Argentina Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F

6.2.6 Argentina Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F

7 Argentina Neurodegenerative Disease Market Import-Export Trade Statistics

7.1 Argentina Neurodegenerative Disease Market Export to Major Countries

7.2 Argentina Neurodegenerative Disease Market Imports from Major Countries

8 Argentina Neurodegenerative Disease Market Key Performance Indicators

8.1 Average waiting time for neurodegenerative disease diagnosis and treatment

8.2 Number of neurologists and healthcare facilities specializing in neurodegenerative diseases per capita

8.3 Percentage of the population covered by health insurance policies that include neurodegenerative disease treatments

9 Argentina Neurodegenerative Disease Market - Opportunity Assessment

9.1 Argentina Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F

9.2 Argentina Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10 Argentina Neurodegenerative Disease Market - Competitive Landscape

10.1 Argentina Neurodegenerative Disease Market Revenue Share, By Companies, 2024

10.2 Argentina Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Neurodegenerative Disease Market

Algeria Neurodegenerative Disease Market

Australia Neurodegenerative Disease Market

Azerbaijan Neurodegenerative Disease Market

Bahrain Neurodegenerative Disease Market

Bangladesh Neurodegenerative Disease Market

Global Neurodegenerative Disease Market

Middle East Neurodegenerative Disease Market

North America Neurodegenerative Disease Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here